Eye drops prescription pattern in patients with glaucoma
Author(s) -
Adriano Santos Souza Carlos,
Brito Rezende Caique,
Ermínia da Rocha Chiara,
Cunha Gois Vinicius,
Pereira de Lyra J uacute nior Divaldo,
Amaral da Silva Francilene
Publication year - 2016
Publication title -
african journal of pharmacy and pharmacology
Language(s) - English
Resource type - Journals
ISSN - 1996-0816
DOI - 10.5897/ajpp2016.4535
Subject(s) - glaucoma , medical prescription , medicine , intraocular pressure , ophthalmology , optometry , latanoprost , open angle glaucoma , glaucoma medication , pharmacology
Glaucoma is a major public health problem, being the leading cause of irreversible visual impairment worldwide. In most cases, glaucoma is associated with intraocular pressure (IOP) levels that are above those considered normal (IOP ≥ 21 mmHg). The aim of the present work is to describe the pattern of eye drops prescription in patients with glaucoma in the state of Sergipe, Brazil. A descriptive cross-sectional study with retrospective documentary analysis, developed at the Eye Institute of Sergipe was performed. Of all glaucoma patients, 41.5% had a family history of the disease. Among the popular drugs, Latanoprost 0.005% is the most requested totaling 34% of prescriptions. In the Region 2, a significant association (c2= 48, 45; p<0.05) was observed between monotherapy and high IOP. The present study showed that the pattern of eye drops prescription was as recommended by the Brazilian Society of Glaucoma. Although, these medications were distributed freely, most patients with glaucoma have high IOP. Therefore, considering the importance of glaucoma as the second cause of blindness worldwide it is essential to carry out studies that evaluate the factors that influenced the effectiveness of eye drops use for treatment of glaucoma. Key words: Glaucoma, ophthalmic solutions, prescription drugs.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom